Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Endometrial Cancer Clinical Trials
Endometrial Cancer clinical trials are recruiting across 141 cities. Here are the cities with the most active studies:
Endometrial Cancer Trial Phases
51 research organizations are sponsoring endometrial cancer trials.
About Endometrial Cancer
Endometrial cancer begins in the lining of the uterus and is the most common gynecologic cancer. It is often detected early due to abnormal bleeding symptoms. Treatment typically involves surgery, with radiation, chemotherapy, or hormone therapy for advanced cases.
Clinical trials are advancing new treatments for endometrial cancer. Currently, 82 studies are recruiting a combined 29,622 participants across the United States. Research is being conducted by 51 organizations including PinkDx, Inc., Exact Sciences Corporation, Mayo Clinic and 48 others.
2026 Endometrial Cancer Research Landscape
As of July 2026, the endometrial cancer clinical trial landscape includes 82 actively recruiting studies across 141 cities in the United States. These studies are collectively seeking 29,622 participants, with an average enrollment target of 361 per study.
The research spans multiple phases of development: 27 studies are in PHASE2, 14 studies are in NA, 13 studies are in PHASE1, 11 studies are in PHASE3, 4 studies are in EARLY_PHASE1. The presence of Phase 3 trials indicates that some endometrial cancer treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 51 different organizations, including PinkDx, Inc., Exact Sciences Corporation, Mayo Clinic, Memorial Sloan Kettering Cancer Center, University of Alabama at Birmingham, and 46 others. The large number of sponsors reflects significant research interest and investment in endometrial cancer treatment advancement.
Geographically, endometrial cancer trials are most concentrated in New York, New York (15 trials); Houston, Texas (12 trials); Miami, Florida (11 trials); Los Angeles, California (11 trials); Boston, Massachusetts (10 trials) and 7 other cities.
Featured Endometrial Cancer Studies
Highlighted recruiting studies for endometrial cancer, selected by enrollment size and research scope.
Investigations of Reproductive Cancers in Women
The goal of this study is to create a non-invasive diagnostic test to rule out gynecological cancer in females aged 45 and older with abnormal uterine or postmenopausal bleeding.
Endometrial Cancer Vaginal Fluid Specimen Collection Study
This is a multicenter, prospective, specimen collection study for development and evaluation of tests used to detect endometrial cancer, other cancers, or their causes.
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
The overarching objective of this project is to develop a pan-gynecologic cancer detection test using gynecologic (unique endometrial, cervical, and ovarian cancer) cancer-specific methylated DNA markers and high-risk human papilloma virus (HR-HPV) detected in vaginal fluid and/or plasma. This proposal defines Phase II MDM-based cancer detection studies in endometrial cancer (EC) and endometrial ...
Frequently Asked Questions About Endometrial Cancer Clinical Trials
Are there endometrial cancer clinical trials near me?
Yes, there are 82 endometrial cancer clinical trials currently recruiting across 141+ cities in the United States, including New York, New York; Houston, Texas; Miami, Florida. Browse the studies above to find one at a location convenient for you.
How do I join a endometrial cancer clinical trial?
To join a endometrial cancer clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are endometrial cancer clinical trials free?
Yes, participation in endometrial cancer clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of endometrial cancer treatments are being studied?
Current endometrial cancer clinical trials are testing a range of approaches across PHASE2 (27 studies), NA (14 studies), PHASE1 (13 studies), PHASE3 (11 studies), EARLY_PHASE1 (4 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 51 research organizations.
Is it safe to participate in endometrial cancer clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov